Genetic models of abnormal apoptosis in lymphocytes

Immunological Reviews

Volumn 169, Issue , 1999, Pages 273-282

  Refaeli, Yosef ^a   Van Parijs, Luk ^b   Abbas, Abul K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; APOPTOSIS; GENETIC MODEL; INFLAMMATION; KNOCKOUT MOUSE; LYMPHOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNITY; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, GENETIC; PROTO-ONCOGENES; RECEPTORS, INTERLEUKIN-2;

EID: 0032811068     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01322.x     Document Type: Review

References (48)

1. 1. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998;280:243-248.
2. 2. Nagata S, Goldstein P. The Fas death factor. Science; 1995;267:1449-1456.
3. 3. Wallach D, Kovalenko AV, Varfolomeev EE, Boldin MP. Death-inducing functions of ligands of the tumor necrosis factor family: a Sanhedrin verdict. Curr Opin Immunol 1998;10:279-288.
4. 4. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-1308.
5. 5. Yang X, Chang HY, Baltimore P. Essential role of CED-4 oligomerization in CED-3 activation and apoptosis. Science 1998;281:1355-1357.
6. 6. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 1995;13:513-543.
7. 7. Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immonul Today 1995;16:39-43.
8. 8. Kuida K, et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998;94:325-337.
9. 9. Zhang J, Cado D, Chen A, Kabra NH, Winoto A. Fas mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort-1. Nature 1998;392:296-300.
10. 10. Yeh WC, et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998;279:1954-1958.
11. 11. Varfolomeev EE, et al. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo-I, and DR3 and is lethal prenatally. Immunity 1998;9:267-276.
12. 12. Cohen PL, Eisenberg RA. The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol Today 1992;13:427-428.
13. + T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. J Immunol 1993;151:7233-7239.
14. 14. Singer GG, Abbas AK. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994;1:365-371.
15. 15. Van Parijs L, Biuckians A, Abbas AK. Functional roles of Fas and Bcl-1-regulated apoptosis of T lymphocytes. J Immunol 1998;160:2065-2071.
16. 16. Kishimoto H, Sprent J. Negative selection in the thymus includes semimature T cells. J Exp Med 1997;185:263-271.
17. + T cells. Nature 1995;376:181-184.
18. 18. Jacobson BA, Panka DJ, Nguyen KA, Erikson J, Abbas AK, Marshak Rothstein A. Anatomy of autoantibody production: dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity 1995;4:509-519.
19. 19. Koh DR, Ho A, Rahemtulla A, Fung-Leung WP, Griesser H, Mak TW. Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur J Immunol 1995;25:2558-2562.
20. 20. Fisher GH, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995;81:935-946.
21. 21. Rieux-Laucat F, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995;268:1347-1349.
22. 22. Wang Y. Nose M, Kamoto T, Nishimura M, Hiai H. Host modifier genes affect mouse autoimmunity induced by the lpr gene. Am J Pathol 1997;151:1791-1798.
23. 23. Walsh CM, Wen BG, Chinnaiyan AM, O'Rourke K, Dixit VM, Hendrick SM. A role for FADD in T cell activation and development. Immunity; 1998;8:439-449.
24. 24. Newton K, Harris AW, Bath ML, Smith K. GC, Strasser A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J 1998;17:706 -718.
25. 25. Van Parijs L, Ibraghimov A, Abbas AK. The roles of costimulation and Fas in T cell ipoptosis and peripheral tolerance. Immunity 1996;4:321-328.
26. 26. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME. Apoptosis signaling by death receptors. Eur J Biochem 1998;254:439-459.
27. 27. Tschopp J, Irmler M, Thome M. Inhibition of fas death signals by FLIPs. Curr Opin Immunol 1998;10:552-528.
28. 28. Irmler M, et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997;388:190-195.
29. 29. Pfeffer K, et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxin shock, yet succumb to L. monocytogenes infection. Cell 1993;73:457-467.
30. 30. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. Interleukin-2 receptor a chain regulates the size and content of he peripheral lymphoid compartment. Immunity 1995;3:541-530.
31. 31. Suzuki H, et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 1995;268:1472-1476.
32. 31. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-261.
33. 33. Contractor NV, et al. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intracpithelial lymphocyte development in colitis-free gnotobiotic Il.-2-deficient mice. J Immunol 1998;160:385-394.
34. 34. Lenardo MJ. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 1991;353:858-861.
35. 35. Van Parijs L, Biukians A, Ibragimov A, Alt FW, Willerford DM, Abbas AK. Functional responses and apoptosis of CD25 (IL-2R α)-deficient T cells expressing a trangenic antigen receptor. J Immunol 1997;158:3738-3745.
36. 36. Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 1998;8:615-623.
37. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-296.
38. 38. Sugamura K, Asao H, Kondo M, Tanaka N, Ishii N, Ohbo K, Nakamura M, Takeshita T. The interleukin-2 receptor γ chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu Rev Immunol 1996; 14:179-205.
39. 39. Denny P, et al. Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene. Diabetes 1997;46:695-700.
40. 40. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996;85:311-318.
41. 41. Rothstein TL, et al. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995;374:163-165.
42. 42. Adams JM. Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-1326.
43. 43. Nunez G, Hockenberry D, McDonnell TJ, Sorensen CM, Korsmeyer SJ. Bcl-2 maintains B cell memory. Nature; 1991;353:71-73.
44. 44. Strasser, A, et al. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 1991;88:8661-8665.
45. 45. Strasser A. Harris AW, von Boehmer H, Cory S. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene. Proc Natl Acad Sci USA 1994;91:1376-1380.
46. 46. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993;75:229-240.
47. 47. Motoyama N, et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-2-deficient mice. Science 1995;167:1506-1510.
48. 48. Van Parijs L, Peterson DA, Abbas AK. The Fas/Fas ligand pathways and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 1998;8:265-274.